MESO

Mesoblast Ltd (MESO)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 1.98B
P/E Ratio
0.00
Revenue (TTM)
$ 17.2M
Volume
0
52W High
$ 22.00
52W Low
$ 6.09
Dividend Yield
0.00%
Beta
1.17

Technicals

50-Day MA
14.5064
200-Day MA
13.899
52 Week High
22
52 Week Low
6.09

About MESO

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary r.

Employees
81
Headquarters
Melbourne, VIC
CEO
Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg